| __timestamp | ADMA Biologics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 4101058 |
| Thursday, January 1, 2015 | 7015946 | 10763215 |
| Friday, January 1, 2016 | 7688238 | 5579049 |
| Sunday, January 1, 2017 | 6229587 | 32051299 |
| Monday, January 1, 2018 | 3926120 | 24482286 |
| Tuesday, January 1, 2019 | 2343848 | 43892589 |
| Wednesday, January 1, 2020 | 5907013 | 44505000 |
| Friday, January 1, 2021 | 3646060 | 79406000 |
| Saturday, January 1, 2022 | 3613764 | 49283000 |
| Sunday, January 1, 2023 | 3300000 | 17282730 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Verona Pharma plc and ADMA Biologics, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Verona Pharma's R&D expenses surged by over 320%, peaking in 2021 with a remarkable $79 million. This reflects their aggressive strategy to expand their pipeline and bring new therapies to market. In contrast, ADMA Biologics experienced a 65% decline in R&D spending, with a notable drop from $9.5 million in 2014 to $3.3 million in 2023. This reduction may indicate a strategic shift or resource reallocation.
These trends highlight the dynamic nature of the biotech industry, where strategic R&D investments can significantly impact a company's future growth and market position.
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Verona Pharma plc
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
R&D Insights: How Summit Therapeutics Inc. and ADMA Biologics, Inc. Allocate Funds
R&D Spending Showdown: Bio-Techne Corporation vs Verona Pharma plc
Analyzing R&D Budgets: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Research and Development Investment: Verona Pharma plc vs CymaBay Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How Verona Pharma plc and MannKind Corporation Allocate Funds
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How ADMA Biologics, Inc. and MiMedx Group, Inc. Allocate Funds